2. Ichiba J. Hiroshima in Korea. 2003. Seoul: Yeok Sa Bi Pyeong Sa.
4. Ju YS, Jhun HJ, Kim JB, Kim JK. Non-cancer diseases of Korean atomic bomb survivors in residence at Hapcheon, Republic of Korea. J Korean Med Sci. 2006. 21:385–390.
Article
5. Sasaki H, Wong FL, Yamada M, Kodama K. The effects of aging and radiation exposure on blood pressure levels of atomic bomb survivors. J Clin Epidemiol. 2002. 55:974–981.
Article
6. Wong FL, Yamada M, Tominaga T, Fujiwara S, Suzuki G. Effects of radiation on the longitudinal trends of hemoglobin levels in the Japanese atomic bomb survivors. Radiat Res. 2005. 164:820–827.
Article
7. Neriishi K, Nakashima E, Delongchamp RR. Persistent subclinical inflammation among A-bomb survivors. Int J Radiat Biol. 2001. 77:475–482.
Article
8. Akahoshi M, Amasaki Y, Soda M, Hida A, Imaizumi M, Nakashima E, Maeda R, Seto S, Yano K. Effects of radiation on fatty liver and metabolic coronary risk factors among atomic bomb survivors in Nagasaki. Hypertens Res. 2003. 26:965–970.
Article
9. Wong FL, Yamada M, Sasaki H, Kodama K, Hosoda Y. Effects of radiation on the longitudinal trends of total serum cholesterol levels in the atomic bomb survivors. Radiat Res. 1999. 151:736–746.
Article
10. Miller M. Raising an isolated low HDL-C level: why, how, and when? Cleve Clin J Med. 2003. 70:553–560.
Article
11. Cullings HM, Fujita S, Funamoto S, Grant EJ, Kerr GD, Preston DL. Dose estimation for atomic bomb survivor studies: its evolution and present status. Radiat Res. 2006. 166:219–254.
Article